PDS Biotechnology (PDSB) analyst forecast and price target
Analyst forecast
Consensus of 2 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $7.00 | Aug 26, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 from $15.00 | Aug 13, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $15.00 | Apr 15, 2026 |
| B. Riley Securities | Maintained | Buy | $3.00 from $5.00 | Nov 25, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $15.00 from $13.00 | Nov 13, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $13.00 | Jul 1, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $13.00 | Jun 11, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $13.00 from $21.00 | Mar 27, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $21.00 | Mar 13, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $21.00 | Mar 7, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $21.00 | Feb 24, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $21.00 | Dec 18, 2024 |
| B. Riley Securities | Maintained | Buy | $7.00 from $9.00 | Nov 25, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $21.00 | Nov 15, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $21.00 | Oct 24, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $21.00 | Oct 2, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $21.00 | Sep 17, 2024 |
| Alliance Global Partners | Maintained | Buy | $7.00 from $5.00 | Aug 20, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $21.00 | Aug 1, 2024 |
| B. Riley Securities | Maintained | Buy | $9.00 from $11.00 | Jun 12, 2024 |
Frequently asked questions
Is PDSB a buy, sell, or hold?
Analysts covering PDS Biotechnology currently average a Buy rating: 2 buy, 0 hold and 0 sell, from 2 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on PDSB?
On Aug 26, 2026, HC Wainwright & Co. maintained PDS Biotechnology at Buy with a price target of $7.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.